Cargando…

P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.

Detalles Bibliográficos
Autores principales: Fazio, F, Di Rocco, A, Za, T, Tomarchio, V, Rago, A, Piciocchi, A, Caravita di Toritto, T, Annibali, O, De Stefano, V, Foà, R, Martelli, M, Petrucci, MT
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009814/
http://dx.doi.org/10.1097/01.HS9.0000829664.02846.2b
_version_ 1784687345507762176
author Fazio, F
Di Rocco, A
Za, T
Tomarchio, V
Rago, A
Piciocchi, A
Caravita di Toritto, T
Annibali, O
De Stefano, V
Foà, R
Martelli, M
Petrucci, MT
author_facet Fazio, F
Di Rocco, A
Za, T
Tomarchio, V
Rago, A
Piciocchi, A
Caravita di Toritto, T
Annibali, O
De Stefano, V
Foà, R
Martelli, M
Petrucci, MT
author_sort Fazio, F
collection PubMed
description
format Online
Article
Text
id pubmed-9009814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-90098142022-04-18 P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY. Fazio, F Di Rocco, A Za, T Tomarchio, V Rago, A Piciocchi, A Caravita di Toritto, T Annibali, O De Stefano, V Foà, R Martelli, M Petrucci, MT Hemasphere Poster Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9009814/ http://dx.doi.org/10.1097/01.HS9.0000829664.02846.2b Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Poster
Fazio, F
Di Rocco, A
Za, T
Tomarchio, V
Rago, A
Piciocchi, A
Caravita di Toritto, T
Annibali, O
De Stefano, V
Foà, R
Martelli, M
Petrucci, MT
P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.
title P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.
title_full P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.
title_fullStr P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.
title_full_unstemmed P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.
title_short P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.
title_sort p23: relapsed/refractory multiple myeloma patients. a multicenter retrospective analysis of eligibility criteria for car-t cell therapy.
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009814/
http://dx.doi.org/10.1097/01.HS9.0000829664.02846.2b
work_keys_str_mv AT faziof p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT diroccoa p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT zat p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT tomarchiov p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT ragoa p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT piciocchia p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT caravitaditorittot p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT annibalio p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT destefanov p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT foar p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT martellim p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy
AT petruccimt p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy